secwatch / observer
8-K filed August 20, 2025, 7:59 PM ET ticker WINT CIK 0000946486
regulatory confidence high sentiment negative materiality 1.00

WINDTREE THERAPEUTICS INC /DE/ (WINT): Nasdaq/NYSE listing notice — Windtree Therapeutics receives Nasdaq delisting notice; stock to trade OTC Aug 21

WINDTREE THERAPEUTICS INC /DE/

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

WINDTREE THERAPEUTICS INC /DE/ received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange
nasdaq
Notice
delisting notice
Deficiency
minimum bid price
Rules
5550(a)(2)
Exact text from the filing
August 19, 2025, Windtree Therapeutics Inc. (the “ Company ” ) was notified by The Nasdaq Stock Market LLC (“ Nasdaq ”) that as a result of the Company’s previously disclosed noncompliance with Nasdaq Listing Rule 5550(a)(2), Nasdaq has determined to delist the Company’s common stock from the Nasdaq Capital Market and, accordingly, will suspend trading in the Company’s common stock effective at the open of trading on August 21, 2025. The Company expects that its common stock will begin trading publicly on the over-the-counter market on August 21, 2025, under its existing symbol “WINT.” The Com
View on SEC.gov

5 listing & compliance notices filed in the last 30 days. Browse all listing & compliance notices →

WINDTREE THERAPEUTICS INC /DE/ filing history →

Source: SEC EDGAR
accession 0001437749-25-027421
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.